Prot# NU MSK 11H01: Phase II Study of Combined Tretinoin and Arsenic Trioxide for Patients with Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date6/15/126/15/18

Funding

  • Memorial Sloan-Kettering Cancer Center (NU MSK 11H01)